Trivalent Chromium Treatment for Rheumatoid Arthritis

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 25, 2022

Primary Completion Date

January 13, 2024

Study Completion Date

January 13, 2024

Conditions

Rheumatoid Arthritis

Interventions

DRUG

Trivalent chromium versus synthetic and/ or biological DMARDs

Supplement and immunesuppressants

Trial Locations (1)

Faculty of Medicine, Alexandria University, Egypt, Alexandria

All Listed Sponsors

lead

Alexandria University

OTHER